FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, namely to gastroenterology, and can be used for gastric eradication of Helicobacter pylori infection. That is ensured by using a surface-active material benzyldimethyl[3-(miristoylamino)propyl]ammonium chloride - C26H47CIN2O.
EFFECT: invention provides gastric eradication of Helicobacter pylori ensured by the absence of resistance of Helicobacter pylori bacterial culture strains to benzyldimethyl[3-(miristoylamino)propyl]ammonium chloride.
2 cl, 2 dwg, 2 tbl
Authors
Dates
2011-10-20—Published
2010-04-15—Filed